Amgen Inc.

Amgen Inc.verified

AMG.DE

Price:

$284.8

Market Cap:

$177.64B

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal nu...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2000-01-03

Stock Exchange

XETRA

Ticker

AMG.DE

The Enterprise Value as of December 2025 (TTM) for Amgen Inc. (AMG.DE) is 222.78B

According to Amgen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 222.78B. This represents a change of 11.31% compared to the average of 200.14B of the last 4 quarters.

Amgen Inc. (AMG.DE) Historical Enterprise Value (quarterly & annually)

How has AMG.DE Enterprise Value performed in the past?

The mean historical Enterprise Value of Amgen Inc. over the last ten years is 166.22B. The current 222.78B Enterprise Value has changed 13.30% with respect to the historical average. Over the past ten years (40 quarters), AMG.DE's Enterprise Value was at its highest in in the September 2024 quarter at 224.41B. The Enterprise Value was at its lowest in in the September 2019 quarter at 134.29B.

Quarterly (TTM)
Annual

Average

166.22B

Median

160.29B

Minimum

140.72B

Maximum

207.76B

Amgen Inc. (AMG.DE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amgen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 20.36%

Maximum Annual Enterprise Value = 207.76B

Minimum Annual Increase = -8.59%

Minimum Annual Enterprise Value = 140.72B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024189.91B-8.59%
2023207.76B20.36%
2022172.62B11.93%
2021154.22B-4.75%
2020161.91B-4.89%
2019170.24B9.37%
2018155.66B-1.89%
2017158.66B12.75%
2016140.72B-6.47%
2015150.46B1.74%

Amgen Inc. (AMG.DE) Average Enterprise Value

How has AMG.DE Enterprise Value performed in the past?

The current Enterprise Value of Amgen Inc. (AMG.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

190.10B

5-year avg

177.28B

10-year avg

166.22B

Amgen Inc. (AMG.DE) Enterprise Value vs. Peers

How is AMG.DE’s Enterprise Value compared to its peers?

Amgen Inc.’s Enterprise Value is greater than Gilead Sciences, Inc. (143.85B), greater than Pfizer Inc. (207.85B), greater than Pfizer Inc. (208.37B), greater than Sanofi (110.45B), less than Merck & Co., Inc. (273.82B), greater than Danaher Corporation (177.44B), greater than Bristol-Myers Squibb Company (141.48B), greater than Boston Scientific Corporation (156.06B), greater than Stryker Corporation (152.54B), greater than Medtronic plc (157.82B),

CompanyEnterprise ValueMarket cap
143.85B$128.91B
207.85B$127.33B
208.37B$126.68B
110.45B$103.60B
273.82B$216.89B
177.44B$140.45B
141.48B$91.74B
156.06B$123.93B
152.54B$118.96B
157.82B$112.87B

Build a custom stock screener for Amgen Inc. (AMG.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amgen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amgen Inc. (AMG.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amgen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Amgen Inc.'s Enterprise Value?

What is the highest Enterprise Value for Amgen Inc. (AMG.DE)?

What is the 3-year average Enterprise Value for Amgen Inc. (AMG.DE)?

What is the 5-year average Enterprise Value for Amgen Inc. (AMG.DE)?

How does the current Enterprise Value for Amgen Inc. (AMG.DE) compare to its historical average?